# US 2021/0227867 A1 · Olive oil enriched with oleanolic acid, process for its preparation and use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0227867 A1
- Document ID: US20210227867A1
- Status: Published application
- Kind: A1
- Application number: 17/258,588
- Filed: 2019-07-08
- Published: 2021-07-29
- Earliest claimed: 2018-07-09
- Assignees: Consejo Superior De Investigaciones Cientificas (Csic); Servicio Andaluz De Salud
- Applicants: Consejo Superior De Investigaciones CientíFicas (Csic); Servicio Andaluz De Salud
- Inventors: Jose Maria CASTELLANO OROZCO; Mirela RADA; Angeles GUINDA GARIN; Jose Manuel SANTOS LOZANO; Jose LAPETRA PERALTA
- Web page: https://patentgrep.com/patent/US20210227867A1

## CPC

- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A23D 9/007: characterised by ingredients other than fatty acid triglycerides
- A23D 9/02: characterised by the production or working-up
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K 9/10: Dispersions; Emulsions
- A61K 31/56: Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K 36/63: Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61K 2236/00: Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- B82Y 5/00: Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- B82Y 40/00: Manufacture or treatment of nanostructures
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23D: EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS (preservation thereof A23B20/00; production, refinement or preservation of animal or vegetable fats or oils C11B, C11C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B82Y: SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES

## Abstract

The present invention relates to an olive oil enriched with oleanolic acid that comprises a concentration of oleanolic acid between 580 and 650 mg/kg. This functional olive has proven to be effective in the treatment and prevention of type 2 Diabetes Mellitus and pre-diabetes. Also, the invention relates to a process for the preparation of said functional olive oil enriched with oleanolic acid.

## Claims

### Claim 1

An olive oil enriched with oleanolic acid (OA) characterized in that the concentration of oleanolic acid in said olive oil is between 580 and 650 mg/kg.

### Claim 2 (depends on 1)

The olive oil according to claim 1, wherein the olive oil is virgin olive oil, extra virgin olive oil, refined olive oil, pomace olive oil or mixtures thereof.

### Claim 3 (depends on 1)

A process to obtain the olive oil enriched with oleanolic acid as defined in claim 1, wherein the process comprises at least the following steps:
1) grinding crystalized OA to produce nanoparticles,
2) adding the OA nanoparticles to a portion of starting olive oil to a concentration between 6000 and 6600 mg/kg to form a nanosuspension,
3) submitting the nanosuspension to treatment by ultrasounds,
4) diluting the nanosuspension to a ratio of between 1:7 and 1:15 with the starting olive oil, and
5) stirring the diluted solution of OA in olive oil at room temperature for between 10 and 15 hours.

### Claim 4 (depends on 3)

The process according to claim 3 wherein the crystalized OA is obtained by a method comprising:
a) extracting oleanolic acid from the leaves of Olea europaea by contacting the leaves of Olea europaea with an organic solvent for a between 30 and 240 minutes in a leaf/solvent ratio of between 1/10-1/50 weight/volume and at a temperature of between 20-70° C.;
b) filtering the extract obtained in step a);
c) concentrating the filtrate obtained in step b) by evaporating the solvent until achieving a volume of between 5% and 20% of the initial one before concentration;
d) applying fractioned crystallization at room temperature, and separation of OA crystals by filtration; and
e) drying the crystalized solid separated in step d) for a period of time of between 5 and 30 minutes and at a temperature of between 130° C. and 220° C.

### Claim 5 (depends on 3)

The process according to claim 3, wherein the grinding is carried out for 2.5 cycles of 10 min at 500 rpm in a planetary micro mill, equipped with agathe balls of 5-10 mm diameter.

### Claim 6 (depends on 5)

The process according to claim 5, wherein between-70-95% by weight in relation to the total weight of the grinded OA nanoparticles obtained in the grinding have an average particle size between 90-300 nm.

### Claim 7 (depends on 3)

The process according to claim 3, wherein the leaves of Olea europaea used in step a) to obtain the crystalized OA are senescent dry leaves.

### Claim 8 (depends on 3)

The process according to claim 3, wherein the ultrasounds of step 3) are carried out at 180 W, 38 QC for 15 min.

### Claim 9 (depends on 3)

The process according to claim 3, wherein the step 3) is carried out without surfactants.

### Claim 10 (depends on 3)

The olive oil enriched with oleanolic acid obtained by the method described in claim 3.

### Claim 11 (depends on 1)

A method of using the olive oil enriched with oleanolic acid according to claim 1, wherein the olive oil enriched with oleanolic acid is used as a medicament.

### Claim 12 (depends on 11)

A method of using the olive oil enriched with oleanolic acid according to claim 11, wherein the olive oil enriched with oleanolic acid is used in the prevention and/or treatment of Diabetes Mellitus type 2 and in the treatment of pre-diabetes.

### Claim 13 (depends on 12)

A method of using the olive oil enriched with oleanolic acid according to claim 12, wherein the olive oil enriched with oleanolic acid is administrated to a subject at a daily dose between 45 and 65 ml.

### Claim 14 (depends on 1)

A pharmaceutical composition comprising the olive oil enriched with oleanolic acid as described in claim 1.

### Claim 15 (depends on 1)

A food composition comprising the olive oil enriched with oleanolic acid as described in claim 1.
